Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences

Abstract

Our previous studies showed that the urokinase-type plasminogen activator receptor (uPAR) and the p16 tumor suppressor gene play a significant role in glioma invasion. We expected that downregulation of uPAR and overexpression of p16 using a bicistronic vector might cause a additive and cooperative effect in the suppression of glioma invasion and growth. The bicistronic construct (Ad-uPAR/p16)-infected glioblastoma cell lines had significantly lower levels of uPAR and higher levels of p16 than controls. Cell cycle analysis showed the bicistronic vector caused G0/G1 arrest of the cell cycle. In vitro glioblastoma cell growth and invasiveness were inhibited in Ad-uPAR/p16-infected cells compared with controls. Ad-uPAR/p16 suppressed the tumor growth of glioblastoma cell lines in an ex vivo intracerebral tumor model and an in vivo subcutaneous tumor model. Our results support the therapeutic potential of simultaneously targeting uPAR and p16 in the treatment of gliomas.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

References

  • Aguirre Ghiso JA, Kovalski K, Ossowski L . 1999 J. Cell Biol. 147: 89–104

  • Andreasen PA, Kjoller L, Christensen L, Duffy MJ . 1997 Int. J. Cancer 72: 1–22

  • Arap W, Nishikawa R, Furnari FB, Cavenee WK, Huang HJ . 1995 Cancer Res. 55: 1351–1354

  • Brooks PC, Clark RA, Cheresh DA . 1994 Science 264: 569–571

  • Chintala SK, Fueyo J, Gomez-Manzano C, Venkaiah B, Bjerkvig R, Yung WK, Sawaya R, Kyritsis AP, Rao JS . 1997 Oncogene 15: 2049–2057

  • Chintala SK, Sawaya R, Gokaslan ZL, Rao JS . 1996 Cancer Lett. 103: 201–208

  • Costello JF, Berger MS, Huang HS, Cavenee WK . 1996 Cancer Res. 56: 2405–2410

  • Dear AE, Medcalf RL . 1998 Eur. J. Biochem. 252: 185–193

  • Ellis V, Pyke C, Eriksen J, Solberg H, Dano K . 1992 Ann. NY Acad. Sci. 667: 13–31

  • Fahraeus R, Lane DP . 1999 EMBO J. 18: 2106–2118

  • Frizelle SP, Grim J, Zhou J, Gupta P, Curiel DT, Geradts J, Kratzke RA . 1998 Oncogene 16: 3087–3095

  • Fueyo J, Gomez-Manzano C, Bruner JM, Saito Y, Zhang B, Zhang W, Levin VA, Yung WK, Kyritsis AP . 1996a Oncogene 13: 1615–1619

  • Fueyo J, Gomez-Manzano C, Yung WK, Kyritsis AP . 1998 Neurology 51: 1250–1255

  • Fueyo J, Gomez-Manzano C, Yung WK, Clayman GL, Liu TJ, Bruner J, Levin VA,, Kyritsis AP . 1996b Oncogene 12: 103–110

  • Gladson CL, Cheresh DA . 1991 J. Clin. Invest. 88: 1924–1932

  • Gladson CL, Pijuan-Thompson V, Olman MA, Gillespie GY, Yacoub IZ . 1995 Am. J. Pathol. 146: 1150–1160

  • Go Y, Chintala SK, Mohanam S, Gokaslan Z, Venkaiah B, Bjerkvig R, Oka K, Nicolson GL, Sawaya R, Rao JS . 1997 Clin. Exp. Metastasis 15: 440–446

  • Go Y, Chintala SK, Oka K, Gokaslan Z, Sawaya R, Rao JS . 1996 Cancer Lett. 110: 225–231

  • Gotoh A, Kao C, Ko SC, Hamada K, Liu TJ, Chung LW . 1997 J. Urol. 158: 636–641

  • Graham FL, Prevec L . 1991 Methods in Molecular Biology. Murray EJ (ed) The Humana Press: Clifton, NJ pp. 109–127

    Google Scholar 

  • Harada H, Nakagawa K, Iwata S, Saito M, Kumon Y, Sakaki S, Sato K, Hamada K . 1999 Cancer Res. 59: 3783–3789

  • Ichimura K, Schmidt EE, Goike HM, Collins VP . 1996 Oncogene 13: 1065–1072

  • Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JK, Kinzler KW, Vogelstein B . 1994 Cancer Res. 54: 6353–6358

  • Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE, Skolnick MH . 1994 Science 264: 436–440

  • Kyritsis AP . 1997 Practice Guidelines for Neurologic Therapy Lechtenberg R and Schutta HS (eds) New York: Marcel Dekker pp. 473–496

    Google Scholar 

  • Kyritsis AP, Zhang B, Zhang W, Xiao M, Takeshima H, Bondy ML, Cunningham JE, Levin VA, Bruner J . 1996 Oncogene 12: 63–67

  • Mignatti P, Rifkin DB . 1993 Physiol. Rev. 73: 161–195

  • Mohan PM, Chintala SK, Mohanam S, Gladson CL, Kim ES, Gokaslan ZL, Lakka SS, Roth JA, Fang B, Sawaya R, Kyritsis AP, Rao JS . 1999 Cancer Res. 59: 3369–3373

  • Mohanam S, Chintala SK, Go Y, Bhattacharya A, Venkaiah B, Boyd D, Gokaslan ZL, Sawaya R, Rao JS . 1997 Oncogene 14: 1351–1359

  • Mohanam S, Chintala SK, Mohan PM, Sawaya R, Lagos GK, Gokaslan ZL, Kouraklis GP, Rao JS . 1998 Int. J. Oncol. 13: 1285–1290

  • Mohanam S, Sawaya R, McCutcheon I, Ali-Osman F, Boyd D, Rao JS . 1993 Cancer Res. 53: 4143–4147

  • Murphy G, Atkinson S, Ward R, Gavrilovic J, Reynolds JJ . 1992 Ann. NY Acad. Sci. 667: 1–12

  • Naruse I, Heike Y, Hama S, Mori M, Saijo N . 1998 Anticancer Res. 18: 4275–4282

  • Nip J, Rabbani SA, Shibata HR, Brodt P . 1995 J. Clin. Invest. 95: 2096–2103

  • Pollanen J, Stephens RW, Vaheri A . 1991 Adv. Cancer Res. 57: 273–328

  • Reed JA, Loganzo FJ, Shea CR, Walker GJ, Flores JF, Glendening JM, Bogdany JK, Shiel MJ, Haluska FG, Fountain JW . 1995 Cancer Res. 55: 2713–2718

  • Sandig V, Brand K, Herwig S, Lukas J, Bartek J, Strauss M . 1997 Nature Med. 3: 313–319

  • Sawaya RE, Yamamoto M, Gokaslan ZL, Wang SW, Mohanam S, Fuller GN, McCutcheon IE, Stetler-Stevenson WG, Nicolson GL, Rao JS . 1996 Clin. Exp. Metastasis 14: 35–42

  • Schreiber M, Muller WJ, Singh G, Graham FL . 1999 Oncogene 18: 1663–1676

  • Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA . 1996 Cell 85: 27–37

  • Vassalli JD, Baccino D, Belin D . 1985 J. Cell Biol. 100: 86–92

  • Walker MD, Green SB, Byar DP, Alexander EJ, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MSJ, Mealey JJ, Owens G, Ransohoff J, Robertson JT, Shapiro WR, Smith KRJ, Wilson CB, Strike TA . 1980 N. Engl. J. Med. 303: 1323–1329

  • Wang J, Guo K, Wills KN, Walsh K . 1997 Cancer Res. 57: 351–354

  • Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, Doyle MV, Chapman HA . 1996 Science 273: 1551–1555

  • Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA . 1994 J. Biol. Chem. 269: 32380–32388

  • Yamamoto M, Sawaya R, Mohanam S, Bindal AK, Bruner JM, Oka K, Rao VH, Tomonaga M, Nicolson GL, Rao JS . 1994a Cancer Res. 54: 3656–3661

  • Yamamoto M, Sawaya R, Mohanam S, Rao VH, Bruner JM, Nicolson GL, Rao JS . 1994b Cancer Res. 54: 5016–5020

  • Yu W, Kim J, Ossowski L . 1997 J. Cell Biol. 137: 767–777

Download references

Acknowledgements

Supported by NIH grants CA 75557 and CA 76350 (JS Rao) and CA80748 (J Fueyo and AP Kyritsis).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jasti S Rao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adachi, Y., Chandrasekar, N., Kin, Y. et al. Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences. Oncogene 21, 87–95 (2002). https://doi.org/10.1038/sj.onc.1204999

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204999

Keywords

This article is cited by

Search

Quick links